Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis -STEP: SporTs Emicizumab Prophylaxis

NCT05022459 is registered in ClinicalTrials.gov with Wayne State University as lead sponsor.

NCT NCT05022459
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05022459 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis -STEP: SporTs Emicizumab Prophylaxis
Lead sponsor
Wayne State University
Phase
Observational
Overall status
Recruiting
Start date
August 16, 2023
Completion date
March 31, 2029
Enrollment
72 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia a